Brown, J. W. L., Cunniffe, N. G., Prados, F., Kanber, B., Jones, J. L., Needham, E., Georgieva, Z., Rog, D., Pearson, O. R., Overell, J., MacManus, D., Samson, R. S., Stutters, J., ffrench-Constant, C., Gandini Wheeler-Kingshott, C. A. M., Moran, C., Flynn, P. D., Michell, A. W., Franklin, R. J. M., Chandran, S., Altmann, D. R., Chard, D. T., Connick, P., & Coles, A. J. (2021). safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study. Lancet neurology, 20(9), 709–720. http://access.bl.uk/ark:/81055/vdc_100144512143.0x00001c